Почетна › Рак (сите типови) › Калифорнија
Клинички испитувања за Рак (сите типови) во Калифорнија
176 студии за Рак (сите типови) бараат учесници на локации во Калифорнија.
Градови во Калифорнија
- Los Angeles74 студии
- Mountain View40 студии
- San Francisco35 студии
- Baldwin Park34 студии
- San Diego32 студии
- Santa Monica22 студии
- Irvine17 студии
- Orange13 студии
- Santa Rosa11 студии
- Sacramento11 студии
- Concord7 студии
- Santa Barbara7 студии
- Huntington Beach6 студии
- San Jose6 студии
- Newport Beach6 студии
- Long Beach6 студии
- Glendale5 студии
- Vallejo5 студии
- Oakland5 студии
- Fullerton5 студии
- Richmond4 студии
- Roseville4 студии
- Fresno4 студии
- Bakersfield3 студии
- Santa Clara3 студии
- Sunnyvale3 студии
- Mission Viejo3 студии
- Modesto3 студии
- Pleasanton3 студии
Официјален текст на студијата (англиски)
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
- City of Hope /ID# 243157, Duarte
- City Of Hope - Seacliff /ID# 263143, Huntington Beach
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 263144, Irvine
- и уште 1
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT04928846PediRISE Feasibility
- University of California San Francisco, San Francisco
Се регрутира
До возраст 17 · Сите полови · Ажурирано 5.10.2026 · NCT06283251Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Keck Medicine of USC, Los Angeles
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT07195591A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- City of Hope National Medical Center /ID# 277005, Duarte
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 277928, Irvine
- UC San Diego Health - Moores Cancer Center /ID# 278836, La Jolla
Се регрутираФаза 2/3
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT07155187A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- City of Hope National Medical Center /ID# 282241, Duarte
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 284734, Irvine
- USC Norris Comprehensive Cancer Center /ID# 275343, Los Angeles
- и уште 3
Се регрутираФаза 2/3
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT07005102A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
- GSK Investigational Site, La Jolla
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT06796907Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
- City of Hope Duarte, Duarte
- University of California at Los Angeles, Santa Monica
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT07529808Distance-Based Exercise to Preserve Function and Prevent Disability
- Kaiser Permanente Dublin, Dublin
- Kaiser Permanente-Fremont, Fremont
- Kaiser Permanente Fresno Orchard Plaza, Fresno
- и уште 10
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT07059884A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- Start Los Angeles /ID# 281533, Los Angeles
Се регрутираФаза 2
Возраст 18 и постари · Жени · Ажурирано 1.10.2026 · NCT07024784A Study of ASP3082 in Adults With Advanced Solid Tumors
- City of Hope National Medical Center, Duarte
- UCLA Santa Monica Hematology Oncology, Santa Monica
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT05382559A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- City of Hope, Duarte
- University of California, Irvine Medical Center - Hematology/Oncology, Orange
- Stanford University School of Medicine, Stanford
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT07192471Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Samsun Clinic - Ridley-Tree Cancer Center, Santa Barbara
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT07566156A Study to Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- City Of Hope Comprehensive Cancer Center /ID# 281939, Duarte
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT07744126A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, Los Angeles
- PHN-012-001 Site, San Diego
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT07127874A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
- City of Hope National Medical Center /ID# 280273, Duarte
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 279067, Irvine
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT07409246Registry Study for Radiation Therapy Outcomes
- California Protons Cancer Therapy Center, San Diego
Се регрутираНабљудувачка студија
Сите возрасти · Сите полови · Ажурирано 29.9.2026 · NCT01255748uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
- Providence St. Johns Health Center, Santa Monica
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT05874921A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
- City of Hope Comprehensive Cancer Center, Duarte
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT06884618A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- Children's Hospital Los Angeles ( Site 4006), Los Angeles
Се регрутираФаза 1/2
1 Month – 17 Years · Сите полови · Ажурирано 25.9.2026 · NCT07630974Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- University of California San Diego, La Jolla
- Stanford University, Palo Alto
- UCLA Medical Center, Santa Monica
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT04981119A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- UC San Diego Medical Center - Encinitas, Encinitas
- Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- UCI Health - Irvine, Irvine
- и уште 14
Се регрутираФаза 2/3
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06989437A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
- City of Hope, Duarte
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06150157A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Sansum Clinic, Santa Barbara
Се регрутираФаза 3
Возраст од 18 до 100 · Сите полови · Ажурирано 25.9.2026 · NCT05920356A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- CBCC Global Research - Comprehensive Blood & Cancer Center, Bakersfield
- TOI Clinical Research, Cerritos
- University of California, San Diego Moores Cancer Center, La Jolla
- и уште 1
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 24.9.2026 · NCT06901531Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 1, Duarte
- Quetzal Site 7, Los Angeles
- Quetzal Site 5, Stanford
Се регрутираФаза 3
Возраст од 18 до 71 · Сите полови · Ажурирано 23.9.2026 · NCT07504458Intratumoral N17350 in Advanced Solid Tumors
- The Angeles Clinic and Research Institute, Los Angeles
- UCLA - Jonsson Comprehensive Cancer Center, Los Angeles
- Scripps Clinic Torrey Pines - La Jolla, San Diego
- и уште 1
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 23.9.2026 · NCT07339176A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- City of Hope National Medical Center /ID# 281322, Duarte
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 281396, Irvine
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 23.9.2026 · NCT07365241TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Sutter Auburn, Auburn
- Sutter Alta Bates, Berkeley
- The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles
- и уште 19
Се регрутираФаза 2
Возраст 12 и постари · Сите полови · Ажурирано 22.9.2026 · NCT02693535Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- UC IRVINE Health, Orange
- UC Davis Comprehensive Cancer Center, Sacramento
- Stanford Cancer Institute, Stanford
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT06128551Prospective Study to Assess a Diagnostic Aid for Cancer
- Southern California Research Center, Coronado
- Palomar Health, Poway
- South Coast Gynecologic Oncology, San Diego
Се регрутираНабљудувачка студија
Возраст 45 и постари · Сите полови · Ажурирано 21.9.2026 · NCT07046260Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- City Of Hope, Duarte
- University Of California San Diego Moores Cancer Center, La Jolla
- University of California, San Francisco- California, San Francisco
- и уште 2
Се регрутираФаза 2/3
Сите возрасти · Сите полови · Ажурирано 18.9.2026 · NCT03435796A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Childrens Hospital Los Angeles ( Site 3006), Los Angeles
Се регрутираФаза 1/2
1 Month – 17 Years · Сите полови · Ажурирано 17.9.2026 · NCT06941272Statins to Prevent Cancer Associated Blood Clots
- City of Hope, Irvine
Се регрутираФаза 4
Возраст 18 и постари · Сите полови · Ажурирано 16.9.2026 · NCT07303816(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- City of Hope Comprehensive Cancer Center, Duarte
- UCLA Medical Center, Los Angeles
- Stanford Cancer Institute, Stanford
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 15.9.2026 · NCT04996875RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Kadima Neuropsychiatry Institute, San Diego
- Providence Medical Foundation, Santa Rosa
Се регрутираФаза 2
Возраст од 18 до 80 · Сите полови · Ажурирано 15.9.2026 · NCT07002034Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
- University of California, San Francisco, San Francisco
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 15.9.2026 · NCT06633224A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
- University of Southern California /ID# 272414, Los Angeles
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 14.9.2026 · NCT06953960Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients
- UC Davis Health, Sacramento
- UC Davis Medical Center, Sacramento
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 11.9.2026 · NCT06722508A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
- University of Southern California Norris Comprehensive, Los Angeles
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 11.9.2026 · NCT06634589A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Research Site, Santa Monica
- Research Site, Santa Rosa
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 11.9.2026 · NCT05123482Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.